Bevacizumab vs ranibizumab treatment for age-related macular degeneration: A head-to-head comparison is needed

Lee M. Jampol

doi:10.1001/archopht.125.4.557

Bevacizumab vs ranibizumab treatment for age-related macular degeneration: A head-to-head comparison is needed

Lee M. Jampol^*

^*Corresponding author for this work

Ophthalmology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	557-558
Number of pages	2
Journal	Archives of ophthalmology
Volume	125
Issue number	4
DOIs	https://doi.org/10.1001/archopht.125.4.557
State	Published - Apr 2007

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1001/archopht.125.4.557

Cite this

@article{7a3ace603f2d4d90a4dcc02150bdb469,

title = "Bevacizumab vs ranibizumab treatment for age-related macular degeneration: A head-to-head comparison is needed",

author = "Jampol, {Lee M.}",

year = "2007",

month = apr,

doi = "10.1001/archopht.125.4.557",

language = "English (US)",

volume = "125",

pages = "557--558",

journal = "JAMA Ophthalmology",

issn = "2168-6165",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Bevacizumab vs ranibizumab treatment for age-related macular degeneration

T2 - A head-to-head comparison is needed

AU - Jampol, Lee M.

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=34247133813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247133813&partnerID=8YFLogxK

U2 - 10.1001/archopht.125.4.557

DO - 10.1001/archopht.125.4.557

M3 - Comment/debate

AN - SCOPUS:34247133813

SN - 2168-6165

VL - 125

SP - 557

EP - 558

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

IS - 4

ER -

Bevacizumab vs ranibizumab treatment for age-related macular degeneration: A head-to-head comparison is needed

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this